R. Woods
Director/Board Member bij X4 PHARMACEUTICALS, INC.
Vermogen: 1 M $ op 31-03-2024
Profiel
Momenteel bekleedt R. Keith Woods de functie van Chief Operating Officer van argenx SE. In zijn vorige carrière bekleedde hij de positie van SVP-North American Operations bij Alexion Pharmaceuticals, Inc. en Vice President & Managing Director bij Alexion Pharma UK Ltd. (een dochteronderneming van Alexion Pharmaceuticals, Inc.). (een dochteronderneming van Alexion Pharmaceuticals, Inc.). Hij behaalde een bachelordiploma aan de Florida State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARGEN-X SE
0.01% | 20-02-2024 | 3 307 ( 0.01% ) | 1 M $ | 31-03-2024 |
X4 PHARMACEUTICALS, INC.
0.05% | 16-10-2023 | 90 000 ( 0.05% ) | 125 100 $ | 31-03-2024 |
Actieve functies van R. Woods
| Bedrijven | Functie | Begin |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Director/Board Member | 16-10-2023 |
| TSCAN THERAPEUTICS, INC. | Director/Board Member | 06-12-2023 |
| ROCKET PHARMACEUTICALS, INC. | Director/Board Member | 12-12-2023 |
Eerdere bekende functies van R. Woods
| Bedrijven | Functie | Einde |
|---|---|---|
| ARGENX SE | Chief Operating Officer | 13-03-2023 |
Alexion Pharma UK Ltd.
 Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Part of AstraZeneca PLC, Alexion Pharma UK Ltd. is a pharmaceutical wholesaler founded in 2006. The private company is based in Middlesex, UK. | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van R. Woods
| Florida State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| ARGENX SE | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Part of AstraZeneca PLC, Alexion Pharma UK Ltd. is a pharmaceutical wholesaler founded in 2006. The private company is based in Middlesex, UK. | Distribution Services |
